When the Navy announced in November the first new portfolio acquisition executive office that rolls dozens of program executive offices and program managers in robotic autonomous systems into a single ...

Real-time data can also be captured by drones during and after flood events. Another technology used is a modeling program called ICM that’s used for large watersheds. It will model underground flow ...

ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

PESHAWAR: Vice-chancellor Khyber Medical University Prof Dr Ziaul Haq has been appointed executive director of Higher Education Commission (HEC) Islamabad. Prof Ziaul Haq is not only the youngest ...

Timothy Li is a consultant, accountant, and finance manager with an MBA from USC and over 15 years of corporate finance experience. Timothy has helped provide CEOs and CFOs with deep-dive analytics, ...

RPSC declares final results for Rajasthan State & Subordinate Services Exam. Check merit list, roll numbers, categories, and PDF at rpsc.rajasthan.gov.in. RPSC RAS final Result out: The Rajasthan ...

The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

Cognitive dissonance happens when you hold two conflicting thoughts in your mind at the same time — like loving both hamburgers and cows. Cognitive dissonance is a theory in social psychology first ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.